BDBM172728 US9096515, 33b -Racemic::US9296681, 33b-Racemic

SMILES CCOc1ccc(cc1)C1(CC(C)CCNCCCC(N)=O)CCC1

InChI Key InChIKey=ZEFQZGJPKZZHJW-UHFFFAOYSA-N

Data  6 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 172728   

TargetSodium-dependent noradrenaline transporter(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM172728(US9096515, 33b -Racemic | US9296681, 33b-Racemic)
Affinity DataKi:  5.49nMAssay Description:The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium-dependent serotonin transporter(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM172728(US9096515, 33b -Racemic | US9296681, 33b-Racemic)
Affinity DataKi:  5.49nMAssay Description:The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM172728(US9096515, 33b -Racemic | US9296681, 33b-Racemic)
Affinity DataKi:  472nMAssay Description:The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM172728(US9096515, 33b -Racemic | US9296681, 33b-Racemic)
Affinity DataKi:  472nMAssay Description:The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium-dependent noradrenaline transporter(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM172728(US9096515, 33b -Racemic | US9296681, 33b-Racemic)
Affinity DataKi: >1.00E+4nMAssay Description:The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium-dependent noradrenaline transporter(Homo sapiens (Human))
Reviva Pharmaceuticals

US Patent
LigandPNGBDBM172728(US9096515, 33b -Racemic | US9296681, 33b-Racemic)
Affinity DataKi: >1.00E+4nMAssay Description:The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. ...More data for this Ligand-Target Pair
In DepthDetails US Patent